Status:
COMPLETED
Effect of a Synbiotic "Probiotical®/Bactecal® " in Asthma
Lead Sponsor:
University of Liege
Collaborating Sponsors:
European Union
Conditions:
Asthma
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
It is a randomized double blind placebo control study. One hundred severe asthmatic patients will receive "Probiotical ®/Bactecal®" each day during 3 months and will be evaluated before and 1-3-6 mont...
Detailed Description
Thirty percent of asthmatic patients are not well controlled even with an optimal treatment. There is then a need for new therapeutics allowing a better asthma control. Synbiotic (association of probi...
Eligibility Criteria
Inclusion
- severe asthma (ACQ \>1.5 and treatment = minimum 200 µg beclomethasone) and stable treatment for at least 3 months.
Exclusion
- treatment not stable
- exacerbation state
- infection
Key Trial Info
Start Date :
January 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT03341403
Start Date
January 17 2017
End Date
September 30 2020
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Liege
Liège, Belgium, 4000